Last update :
03/05/2024
References   References 754  
Type : Manufacturer

Research teams :
Authors :
Title : Infliximab (Remicade®) – Summary of Product Characteristics
Reference : Merck Sharp & Dohme 2019

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionInfliximab Immunosuppressant
Stability in solutions Glass Water for Injection 10 mg/ml 2-8°C Not specified
28 Day
Stability in solutions Not specified Sodium chloride 0,9% < 4 mg/ml 2-8°C Not specified
28 Day

  Mentions Légales